Josh Silverman

Josh Silverman

Company: Aromyx Corp.

Job title: CEO


Dr. Silverman has 20 years of experience in new biotechnology research, development and commercialization. Before joining Aromyx he was Founder and Chief Technology Officer of Calysta, Inc., where he led development of technology converting methane gas to protein using bacteria. Previously, he was Vice President of Drug Development at Amunix, Inc.  Dr. Silverman co-founded Versartis, Inc. in 2008 and participated in the founding and financing of four startup biotechnology companies (Avidia, Diartis, Siluria and Calysta). He has held positions at two public biotechnology companies, Maxygen, Inc. and Amgen, Inc.

Dr. Silverman earned his B.Sc. in Molecular Biology from UC San Diego and his Ph.D. in Biochemistry from Stanford University.


Smart Reformulation Technology: Using Data Science in Rapid Reformulation Efforts 12:17 pm

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.